Kwality Pharmaceuticals share news, announcements and annual reports
NSE: KPLBSE: 539997Pharmaceuticals & BiotechnologySmall Cap
Kwality Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2016
Last close ₹3,680.60down ₹16.10 (0.44%)BSE ₹3,680.95
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,696.70.
29 Oct: open ₹3,678.30, high ₹3,711.90, low ₹3,601.10
52-week range of BSE trades to 29 Oct 2026
₹828.80Low, 11 Nov 2025₹3,866.55High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,819 Cr1,235th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 47.12
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.52
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 19,01139.8% delivered
Kwality Pharmaceuticals board meetings
87 filed, newest first. Page 2 of 2.
Aug 2022
4 Aug · Board meeting
Meeting on 13 Aug 2022: quarterly results
May 2022
18 May · Board meeting
Meeting on 28 May 2022: half yearly results and audited results
Nov 2021
2 Nov · Board meeting
Meeting on 10 Nov 2021
Oct 2021
12 Oct · Board meeting
Meeting on 22 Oct 2021: half yearly results
Sep 2021
Jun 2021
23 Jun · Board meeting
Meeting on 30 Jun 2021: audited results and half yearly results
Nov 2020
9 Nov · Board meeting
Meeting on 13 Nov 2020: half yearly results
Jun 2020
Nov 2019
7 Nov · Board meeting
Meeting on 14 Nov 2019: half yearly results
Sep 2019
Jul 2019
Jun 2019
May 2019
23 May · Board meeting
Meeting on 30 May 2019: audited results
Nov 2018
Sep 2018
Aug 2018
May 2018
19 May · Board meeting
Nov 2017
Sep 2017
Aug 2017
May 2017
Mar 2017
Dec 2016
Sep 2016